| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |